Together with high expression level of MAP7D1 in bone marrow, these findings suggest that the mitotic aberrations seen in SDS patient fibroblasts carrying the MAP7D1:p.R201W mutation may contribute to bone marrow failure and leukemogenesis, similar to those seen in SDS patients that carry SBDS mutations. The gene discussed is MAP7D1; the disease is Bone marrow hypocellularity.